Risk factors for carbapenem-resistant Klebsiella pneumoniae infection in hospitalized patients: a meta-analysis
Quick Take: Aggressive mitigation of modifiable risk factors—specifically invasive device duration and antimicrobial exposure—is the primary driver in reducing nosocomial CRKP transmission.
💡 Clinical Impact
- Pathogen Containment: Shifting the clinical focus from "Reactive Treatment" (which is often futile given resistance profiles) to "Upstream Prevention" through colonized-patient isolation and environmental decolonization.
- Stewardship Synergy: Validates that strict Carbapenem and Fluoroquinolone stewardship is not just about resistance prevention, but about maintaining the patient's protective commensal flora.
- Device-Related Vulnerability: Highlights that the "Invasive Device Clock" (central lines, catheters, ventilators) is the single most actionable metric for ICU-acquired CRKP.
📊 Evidence Breakdown
Evidence Grade: 🟢 9/10 (High Fidelity)
Analysis: This meta-analysis provides a "Clean Signal" by pooling data from multiple high-acuity settings. The 9/10 score reflects the consistency of the risk-factor profile (antibiotic pressure and device use) across diverse global hospital systems.
Note: While the "risk" is well-defined, the "intervention" efficacy remains subject to the quality of local nursing and environmental services (EVS) compliance.
🩺 Practice Recommendation
Mandatory Prevention Bundle: Do not wait for a positive culture to act. Implement a "CRKP Hardening" protocol for all ICU admissions:
- Daily Device Audit: Mandatory "line-stripping" or justification for every invasive device.
- Antibiotic Time-Out: 48-hour review of all broad-spectrum coverage.
- Glycemic Strictness: Maintain stable blood glucose to prevent impaired neutrophil function, a key host-side vulnerability.